N. Kapsala

Demyelinating Syndromes in Systemic Lupus Erythematosus: Data From the “Attikon” Lupus Cohort

M. Papathanasiou, D. Nikolopoulos, D. Boumpas, 2022, Frontiers in Neurology.

Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patients

K. Thomas, D. Vassilopoulos, D. Boumpas, 2021, Arthritis Research & Therapy.

Familial Mediterranean Fever Mimicking Whipple’s Disease: A Case Report and Review of the Literature

C. Damoulari, S. Flouda, N. Kapsala, 2022, Mediterranean journal of rheumatology.

AB0633 Health-Related Quality of Life in ANCA Vasculitides and Rheumatoid Arthritis patients: a cross-sectional comparative study

K. Thomas, D. Vassilopoulos, E. Argyriou, 2022, Annals of the Rheumatic Diseases.

Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study

A. Elezoglou, D. Nikolopoulos, D. Boumpas, 2023, Frontiers in Immunology.

First diagnosis of systemic lupus erythematosus in hospitalized patients: Clinical phenotypes and pitfalls for the non-specialist.

D. Nikolopoulos, D. Boumpas, G. Bertsias, 2021, The American journal of medicine.

Transcriptomic and proteomic profiling reveals distinct pathogenic features of peripheral non-classical monocytes in systemic lupus erythematosus.

A. Fanouriakis, A. Banos, N. Kapsala, 2023, Clinical immunology.

Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events

D. Nikolopoulos, G. Bertsias, A. Fanouriakis, 2024, Annals of the rheumatic diseases.